 |
Synthetic human secretin |
|---|---|
| Trade Name | |
| Orphan Indication | For use in conjunction with diagnostic procedures (excluding ERCP) for pancreatic disorders to increase pancreatic fluid secretion |
| USA Market Approval | USA |
| USA Designation Date | 2006-09-18 00:00:00 |
| Sponsor | Innovate Biopharmaceuticals, Inc.;8601 Six Forks Road, Suite 400;Raleigh, North Carolina, 27615 |
